CDK4/6 inhibitors: a brief overview and prospective research directions

por Adon, Tenzin, Shanmugarajan, Dhivya, Kumar, Honnavalli Yogish
Publicado 2021

Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules

por Ramya, Krishnappa, Suresh, Ramalingam, Kumar, Honnavalli Yogish, Kumar, B.R. Prashantha, Murthy, N.B. Sridhara
Publicado 2020